Clinical Trial Update: Helium-3 MRI Imaging Study in COPD [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating helium-3 MRI imaging for assessing lung ventilation in chronic obstructive pulmonary disease has completed. Sponsor: GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED